Medicare Enrolled
Dr. Irina Kogan, M.D.
Neurology · Brooklyn, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Kogan from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kogan?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Kogan
Dr. Irina Kogan is a neurology specialist in Brooklyn, NY, with 18 years of NPI registration. Based on federal Medicare data, Dr. Kogan performed 1,273 Medicare services across 852 unique beneficiaries.
Between the years covered by Open Payments, Dr. Kogan received a total of $13,869 from 54 pharmaceutical and/or device companies across 598 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kogan is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 24% volume in NY
$13,869 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,273
Medicare services
Top 24% in NY for neurology
852
Unique beneficiaries
$108
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~71 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
562 | $67 | $102 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
177 | $99 | $143 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
162 | $91 | $192 |
| Nerve conduction study, 9-10 studies A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function. |
82 | $196 | $406 |
| Awake and drowsy EEG A test that records electrical activity in the brain while the patient is awake and drowsy. |
59 | $362 | $598 |
| Digital analysis of brain wave activity (EEG) This procedure involves the digital analysis of brain wave activity recorded via an electroencephalogram (EEG). It focuses on the technical interpretation of the digital data rather than the initial recording or supervision. |
46 | $260 | $442 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
44 | $118 | $245 |
| Balance testing with recording A procedure to evaluate balance function by recording the results during testing. |
26 | $96 | $214 |
| Use of electrodes during balance testing Application of electrodes to monitor physiological responses during a balance assessment. |
26 | $10 | $85 |
| Balance and posture test A test to evaluate a patient's balance and posture. This assessment measures stability and body alignment. |
26 | $43 | $211 |
| Vestibular function test using rotating chair This test evaluates eye movement and balance function by having the patient sit in a rotating chair. It helps assess how the inner ear and brain coordinate to maintain stability. |
25 | $112 | $247 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
23 | $155 | $306 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
15 | $163 | $268 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$13,869
Total received (2018-2024)
Avg $1,981/year across 7 years
Top 21% in NY for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
54
Companies
598
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,816 (99.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$53 (0.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,783
2023
$2,847
2022
$2,730
2021
$2,909
2020
$1,482
2019
$1,195
2018
$922
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$385
Neurocrine Biosciences, Inc.
$348
PFIZER INC.
$273
SCILEX PHARMACEUTICALS INC.
$204
Otsuka America Pharmaceutical, Inc.
$202
Teva Pharmaceuticals USA, Inc.
$162
Lilly USA, LLC
$38
Genentech USA, Inc.
$25
Amneal Pharmaceuticals LLC
$25
Takeda Pharmaceuticals U.S.A., Inc.
$25
Alkermes, Inc.
$25
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$21
Biogen, Inc.
$20
AstraZeneca Pharmaceuticals LP
$15
UCB, Inc.
$15
Top 3 companies account for 56.5% of 2024 payments
All-time payments by company (2018-2024) ›
Teva Pharmaceuticals USA, Inc.
$1,513
ABBVIE INC.
$1,351
Neurocrine Biosciences, Inc.
$910
Otsuka America Pharmaceutical, Inc.
$771
Amgen Inc.
$687
SK Life Science, Inc.
$620
Alkermes, Inc.
$530
PFIZER INC.
$515
Biohaven Pharmaceutical Holding Company Ltd.
$508
Eisai Inc.
$452
Biohaven Pharmaceuticals, Inc.
$428
UCB, Inc.
$420
Allergan, Inc.
$375
Novartis Pharmaceuticals Corporation
$375
Lilly USA, LLC
$365
Scilex Pharmaceuticals Inc.
$354
SCILEX PHARMACEUTICALS INC.
$336
EISAI INC.
$320
GENZYME CORPORATION
$242
AbbVie Inc.
$211
Almatica Pharma LLC
$208
Acorda Therapeutics, Inc
$178
Avanir Pharmaceuticals, Inc.
$168
ASSERTIO THERAPEUTICS, Inc.
$165
Assertio Therapeutics, Inc.
$163
JAZZ PHARMACEUTICALS INC.
$162
IMPEL PHARMACEUTICALS INC.
$157
Horizon Therapeutics plc
$145
Biogen, Inc.
$142
ARBOR PHARMACEUTICALS, INC.
$121
Sunovion Pharmaceuticals Inc.
$101
Supernus Pharmaceuticals, Inc.
$97
Amneal Pharmaceuticals LLC
$91
Currax Pharmaceuticals LLC
$71
ITI, Inc.
$63
Alexion Pharmaceuticals, Inc.
$58
Neurelis, Inc.
$55
LivaNova USA, Inc.
$54
ARGENX US, INC.
$46
ACADIA Pharmaceuticals Inc
$43
Upsher-Smith Laboratories LLC
$42
Genentech USA, Inc.
$25
Takeda Pharmaceuticals U.S.A., Inc.
$25
BioXcel Therapeutics, Inc.
$23
Corium, LLC
$23
Celgene Corporation
$22
Janssen Pharmaceuticals, Inc
$22
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$21
Harmony Biosciences LLC
$20
Vertical Pharmaceuticals, LLC
$16
Medtronic USA, Inc.
$16
Lundbeck LLC
$15
AstraZeneca Pharmaceuticals LP
$15
Promius Pharma LLC
$14
Top 3 companies account for 27.2% of all-time payments
Associated products mentioned in payments ›
ABILIFY MAINTENA · ABILIFY MYCITE · ACTIVA · ADUHELM · AFINITOR · AIMOVIG · AJOVY · AMPYRA · APTIOM · ARISTADA · AUBAGIO · AUSTEDO · AZSTARYS · Aimovig · Austedo XR · BOTOX · Briviact · CAPLYTA · COMIRNATY · CONTRAVE · CREXONT · Cambia · Cenobamate · DUEXIS · ELIQUIS · EMGALITY · EPIDIOLEX · Edarbi · Enspryng · Fycompa · GILENYA · GRALISE · Gralise · Horizant · IGALMI · INBRIJA · INGREZZA · INVEGA SUSTENNA · NAPRELAN · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · ONGENTYS · OXTELLAR XR · Ongentys · PAXLOVID · POMPE - DISEASE · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · RAYOS · RELEXXII · REXULTI · RYTARY · SOLIRIS · TECFIDERA · TRINTELLIX · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · UZEDY · VALTOCO · VIVITROL · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VNS Therapy · VRAYLAR · VUMERITY · VYEPTI · VYVGART · Vimpat · Wakix · ZEMBRACE SYMTOUCH · ZEPOSIA · ZTLido · Zipsor
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Neurologists within 10 mi
1,205
Per 100K population
45.5
County median income
$78,548
Nearest hospital
NEW YORK COMMUNITY HOSPITAL OF BROOKLYN, INC.
1.8 mi
1.8 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Kogan is a clinical cardiology specialist, with above-average Medicare volume (top 24% in NY), with low-engagement industry engagement, with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Kogan experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Kogan performed 562 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kogan receive payments from pharmaceutical companies?
Yes. Dr. Kogan received a total of $13,869 from 54 companies across 598 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kogan's costs compare to other neurologists in Brooklyn?
Dr. Kogan's average Medicare payment per service is $108. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kogan) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Brooklyn
Browse neurologists in Brooklyn ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in NY
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in NY
Which NY neurologists receive the most from drug and device companies.
By company
Teva Pharmaceuticals USA, Inc. Payments to Doctors
See all physicians who received payments from Teva Pharmaceuticals USA, Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Neurocrine Biosciences, Inc. Payments to Doctors
See all physicians who received payments from Neurocrine Biosciences, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology